Search Results
Site Search
Testing Archives - Page 26 of 26 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Ganglioside-associated neuropathies - Insights
Learn how Mayo Clinic Laboratories’ ganglioside antibody evaluation can provide diagnostic clarity and a path forward for patients impacted by autoimmune peripheral neuropathy.
Check out Mayo Clinic Laboratories’ biochemical and molecular testing options to diagnose creatine deficiency disorders.
New Tests Launched in October - Insights
In October 2019, Mayo Clinic Laboratories announced seven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Neuroimmunology: Updates and antibody test utilization - Insights
In this month’s “Hot Topic,” Andrew McKeon, M.B., B.Ch., M.D., reviews the use of neurological phenotype-based evaluations, the move away from the paraneoplastic evaluation, and upcoming changes to test profiles.
Mayo Clinic Laboratory and pathology research roundup: July 5 - Insights
This week’s research roundup features: The publication impact of the first 100 THOR Network publications by bibliometric and social network analyses.
Next-generation sequencing - Insights
Browse our full menu of genetic testing, which provides the highest quality molecular assays available.
The Power of Discovery: Mayo Clinic Laboratories Autoimmune Neurology Service - Insights
Autoimmune neurological disorders can often be treated, sometimes with full restoration of function. However, because the symptoms mimic other conditions, autoimmune neurological disorders are frequently misdiagnosed, resulting in an...
Myasthenia Gravis Testing - Mayo Clinic Laboratories
Our diagnostic algorithms consist of tests that are always performed, and then additional testing is performed depending on the initial results.
Mayo Clinic Laboratories has launched a first-in-the-U.S. autoimmune test of the Kelchlike protein 11 antibody, or KLHL11, which is used to detect autoimmune disease associated with testicular cancer.
infectious_endocarditis_diagnostic_testing_for_identification_of_microbiological_etiology.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 08/2023 This algorithm is intended for use in patients with clinical and/or echocardiographic findings suggestive of infective endocarditis, based on the...
December 2023 - Clinical Microbiology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology.
The assay is now recommended for diagnosing and monitoring patients with monoclonal protein disorders and exclusively available through Mayo Clinic Laboratories– Rochester.
Mayo Clinic Laboratory and Pathology Research Roundup: July 3 - Insights
This week’s Research Roundup highlights the comparison of gadolinium concentrations within multiple rat organs after intravenous administration of linear versus macrocyclic gadolinium chelates.
Learn more about Mayo Clinic Laboratories’ testing to identify and monitor nicotine use as part of a patient’s nicotine-use cessation treatment plan, before anesthesia/surgery, or as part of insurance policy assessments.
Mayo Clinic Laboratory and pathology research roundup: November 15 - Insights
This week's research roundup features: Renin production by juxtaglomerular cell tumors and clear cell renal cell carcinoma and the role of angiotensin signaling inhibitors
MCLRequest for Supplies MC0748
MCLRequest Supplies Complete print Request Supplies Reset Form Client Information required Client Account Number Client Contact Phone Date
Complex testing offers answers and guidance about a lifelong illness - Insights
For patients with chronic lymphocytic leukemia (CLL) — the most common leukemia in adults — advanced testing can not only provide valuable information about their disease state, but peace of mind in the face of a progressive, incurable...
CPT Codes and LOINC Update: September 2020 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of September
Mayo Clinic Laboratory and Pathology Research Roundup: July 17 - Insights
This week’s Research Roundup highlights postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease.
Learn more about Mayo Clinic Laboratories testing for pregnancy loss, which can help determine causes and risk of recurrence for future pregnancies.
Mitochondrial disease - Insights
Learn about our four molecular testing options, which can be used to confirm a diagnosis and identify a specific mitochondrial syndrome.
Autoimmune Axonal Evaluation - Insights
Div Dubey, M.B.B.S., explains Mayo Clinic Laboratories' phenotypic testing approach for autoimmune axonal neuropathy. The comprehensive, serologic panel detects for antibodies with clinical relevance to the disease to provide clarity on...
CPT codes and LOINC update: January 2022 - Insights
CPT code updates posted to mayocliniclabs.com during the month of January.
Part II of this series shows how a breakthrough discovery about how kidney stones form may open the way for new, unorthodox treatments. The discovery was made possible by joining University of Illinois’ geology and biology forces with Mayo...
The National Kidney Foundation, the American Society for Clinical Pathology, and the nation’s leading laboratories and clinical laboratory societies have announced a new collaboration to remove barriers to testing for chronic kidney...
Hot Topic Archives - Page 4 of 5 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 17 - Insights
This week’s Research Roundup highlights the risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics.
Aiming to advance understanding of hard-to-predict gastroenteropancreatic neuroendocrine tumors (GEP-NETs), Thermo Fisher Scientific joined forces with Mayo Clinic and BioPharma Diagnostics to validate and gain U.S. regulatory clearance of...
Avoid seller's remorse: Why owning your lab makes sense - Insights
For community health care providers, owning a laboratory has been likened to shoveling money down a giant drain. Cayuga Medical Center is challenging that narrative. Instead of selling, Cayuga is investing in its lab — which it considers a...
New tests launched in November - Insights
In November 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Collaboration Paves the Way for Rapid Discovery in Autoimmune Neurology - Insights
Using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and University of California, San Francisco (UCSF), have discovered an autoimmune disease that appears to affect men with testicular cancer.
Testing Archives - Page 4 of 26 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Matthew Binnicker, Ph.D., discusses the need for laboratory testing for the diagnosis and management of fast-spreading viral infections.
At the recent AACC annual scientific meeting, Melissa Snyder, Ph.D., Consultant in the Division of Clinical Biochemistry and Immunology at Mayo Clinic in Rochester, Minnesota, presented the short course, “Clinical and Laboratory Aspects of...
Rapidly progressive dementia - Insights
Mayo Clinic Laboratories’ first-in-class testing for rapidly progressive dementia and Creutzfeldt-Jakob disease uses a sensitive and specific seed amplification assay that detects and identifies prion proteins in CSF alongside a clinically...
Mayo Clinic Laboratory and Pathology Research Roundup: March 12 - Insights
This week's research roundup feature: C3 glomerulopathy (C3G) is a rare disease resulting from dysregulation of the alternative pathway of complement. C3G includes C3 glomerulonephritis (C3GN) and dense deposit disease (DDD), both of which...
Communiqué Archives - Insights
Skip to Content MayoACCESS MayoLINK...
As part of Mayo Clinic’s Neuro-Oncology practice, the Division of Laboratory Genetics and Genomics tests about 50 brain tumors a week, and upwards of 1,500 brain tumors a year from all over the world.
Then and now: Upholding Mayo Clinic's core values - Insights
Part two of the 50th Anniversary series highlights how Mayo Clinic Laboratories has remained focused on our core values through support of Mayo Clinic’s three shields – integrated clinical practice, research, and education.
Building the business of lab medicine - Insights
In part three of the 50th Anniversary series, Mayo Clinic Laboratories looks further outside the walls of Mayo Clinic. With the belief that the latest in diagnostic testing should be available to any patient, no matter where they are...
The evolution of specimen accessioning and delivery - Insights
The last installment of our 50th Anniversary series explores how Mayo Clinic Laboratories pioneered best practices in the area of specimen accessioning and delivery.
Enhanced technology safeguards patient specimens - Insights
Mayo Clinic's use of enhanced radio-frequency identification technology to track specimens from the clinical setting to the lab reduces the risk of errors and protects valuable — sometime irreplaceable — patient samples.
The birth of Mayo Clinic Laboratories: From tiny operation to international mainstay - Insights
In 1971, the Regional Laboratory, later to become Mayo Clinic Laboratories, was founded. For the first time in Mayo Clinic’s history, the institution would support the community practice of pathology for outside patients in the region and...
Testing for a surprising antigen enables insight into a chronic kidney illness - Insights
Mayo Clinic renal pathologist Dr. Sanjeev Sethi identified NELL-1 as a biomarker for membranous nephropathy (MN) in 2019. Two years later, Dr. Sethi helped implement the first ever IHC test to detect NELL-1 antigen, which appears in about...
Helicobacter pylori Infection: Serologic Testing Not Recommended [Communiqué] - Insights
Helicobacter pylori (H pylori) infection is among the most common bacterial infections worldwide with approximately one-half of the world’s population infected. Several invasive and noninvasive testing methods are available to detect H...
Defying all odds and exploring a remarkable journey beyond diagnosis: Mike Knudson - Insights
In August of 2021, 28-year-old Mike Knudson, a Twin Cities resident known for his vibrant and active lifestyle, set out on what he anticipated to be an adventurous hiking vacation to the picturesque Glacier National Park in Montana. Little...
Liver Disease Testing - Mayo Clinic Laboratories
Mayo Clinic Laboratories offers the only comprehensive testing menu for liver disease developed by clinical experts that enables health care providers to determine the underlying cause and rule out other causes for the disease.
A Test in Focus Archives - Page 2 of 11 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Find out how our pediatric oncology testing was designed to deliver individualized insights to confirm diagnosis and guide treatment.